EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

QKL injection ameliorates Alzheimer's disease-like pathology by regulating expression of RAGE

Jinfang Dou, Xin'ai Zhang, Chaoqun Hu, Yuqian Gao, Yue Zhao, Murong Hei, Zhimiao Wang, Nan Guo, Haiyan Zhu

Experimental Gerontology · 2024

DOI: 10.1016/j.exger.2024.112422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Gerontology, 2024. Verfasst von Jinfang Dou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beijing University of Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Receptor for Advanced Glycation End Products, Amyloid beta-Peptides, Disease Models, Animal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chengdu University of Traditional Chinese Medicine, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The onset of Alzheimer's disease is related to neuron damage caused by massive deposition of Aβ in the brain. Recent studies suggest that excessive Aβ in the brain mainly comes from peripheral blood, and BBB is the key to regulate Aβ in and out of the brain. In this study, we explored the pathogenesis of AD from the perspective of Aβ transport through the BBB and the effect of QKL injection in AD mice. The results showed that QKL could improve the cognitive dysfunction of AD mice, decrease the level of Aβ and Aβ transporter-RAGE, which was supported by the results of network pharmacology, molecular docking and molecular dynamics simulation. In conclusion, RAGE is a potential target for QKL's therapeutic effect on AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseReceptor for Advanced Glycation End ProductsAmyloid beta-PeptidesDisease Models, AnimalAnimalsMiceBlood-Brain BarrierMaleMolecular Docking SimulationMice, TransgenicMolecular Dynamics SimulationBrainCognitive Dysfunction

Stichwörter der Autor:innen

Alzheimer's diseaseMolecular dockingNetwork pharmacologyQKL injectionReceptor for advanced glycation end productsβ-Amyloid

Substanzen

Receptor for Advanced Glycation End ProductsAmyloid beta-PeptidesAger protein, mouse

Autor:innen und Institutionen

  • Beijing University of Chinese Medicine, Beijing, China.
  • Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.
  • Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China. Electronic address: brandy396@163.com.
  • Beijing University of Chinese Medicine, Beijing, China; Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China. Electronic address: zhuhaiyangy@163.com.

Förderung

  • Chengdu University of Traditional Chinese Medicine
  • National Natural Science Foundation of China

Zitieren

APA

Dou, J., Zhang, X., Hu, C., Gao, Y., Zhao, Y., Hei, M., Wang, Z., Guo, N., & Zhu, H. (2024). QKL injection ameliorates Alzheimer's disease-like pathology by regulating expression of RAGE. Experimental Gerontology. https://doi.org/10.1016/j.exger.2024.112422

Vancouver

Dou J, Zhang X, Hu C, Gao Y, Zhao Y, Hei M, et al. QKL injection ameliorates Alzheimer's disease-like pathology by regulating expression of RAGE. Experimental Gerontology. 2024. doi:10.1016/j.exger.2024.112422

BibTeX
@article{Dou2024,
  author = {Dou, Jinfang and Zhang, Xin'ai and Hu, Chaoqun and Gao, Yuqian and Zhao, Yue and Hei, Murong and Wang, Zhimiao and Guo, Nan and Zhu, Haiyan},
  title = {QKL injection ameliorates Alzheimer's disease-like pathology by regulating expression of RAGE},
  journal = {Experimental Gerontology},
  year = {2024},
  doi = {10.1016/j.exger.2024.112422}
}
Kostenlos starten →